TORNO CAPITAL, LLC

Position in ACLX — Arcellx, Inc.

CIK 1974312 COHASSET, MA

Back to ACLX Full portfolio

Position in ACLX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$836,463

+$669,443 QoQ

Shares Held

7,285

+264.2% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.54%

of 13F equity value

Holder Rank

#133

of 238 holders

Holding Since

Sep 2024

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACLX Over Time

Shares Held

Position Value (USD)

Derivatives in ACLX

reported options exposure · as of Sep 30, 2024

CallValue

CallShares

PutValue

$835,100

PutShares

10,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

TORNO CAPITAL, LLC holds $2,431,577 across 4 Biotechnology names. ACLX ranks #1 (34.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ACLX	Arcellx, Inc. This page	7,285	$836,463
2	CNTA	Centessa Pharmaceuticals plc	20,000	$794,400
3	PLRX	Pliant Therapeutics, Inc.	350,000	$441,000
4	KZR	Kezar Life Sciences, Inc.	48,479	$359,714

All Filings in ACLX

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$836,463	7,285	+264.2%	Shares	Sole	2026-05-15
2024-09-30	$167,020	2,000	-80.0%	Shares	Sole	2025-05-14
2024-09-30	$835,100	10,000	—	Put	Sole	2025-05-14
No filing history on record for this holder in this stock.